About
VUNO Inc. is a South Korean company that specializes in AI-driven medical software solutions. Founded with the mission to "View the Invisible, Know the Unknown," VUNO focuses on using artificial intelligence to address medical complexities and improve early disease detection, prevention, and treatment outcomes. The company is headquartered in Seoul and has a U.S. corporate office, and it is publicly listed on the Korean KOSDAQ stock exchange. VUNO offers a range of AI-powered medical solutions designed to assist healthcare professionals. Their products include VUNO Med®-Fundus AI™, an innovative tool for retinal imaging analysis; VUNO Med®-DeepBrain™, an FDA-cleared solution for brain imaging; and VUNO Med®-Chest X-ray™ Triage, which analyzes chest X-rays. Their solutions span various medical fields, including radiology, pathology, cardiology, and ophthalmology, aiming to enhance diagnostic accuracy and improve patient care. VUNO serves medical institutions and healthcare providers, with a growing presence in international markets.
Technologies
Keywords
Company Information
-
Employees 99
-
Founded 2014
-
Annual Revenue $21984000
Location
Seoul, Seoul, South Korea, 06541